Research on the Application of Surface-Enhanced Raman Spectroscopy (SERS) in Blood Glucose Monitoring for Diabetes

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2500109647

Enrollment

Unknown

Registered

2025-09-23

Start date

2025-09-25

Completion date

Unknown

Last updated

2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Interventions

Trial group:NA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients or healthy individuals who completed HbA1c testing at the Endocrinology and Diabetes Department outpatient clinic of The First Affiliated Hospital of Xiamen University.

Exclusion criteria

Exclusion criteria: 1. Conditions affecting erythrocyte survival: hemolytic anemia, significant blood loss, splenomegaly, rheumatoid arthritis, chronic liver disease; along with medical history of splenectomy, aplastic anemia, vitamin B12 deficiency, and renal impairment. 2. Patients on long-term supplementation of vitamin C, vitamin E, or acetylsalicylate. 3. Chronic alcohol abuse; 4. Pregnant women; 5. Severe jaundice or hyperlipidemia;

Design outcomes

Primary

Measure	Time frame
HbA1c;	—

Countries

China

Contacts

Public ContactLiu Changqin

The First Affiliated Hospital of Xiamen University

liuchangqin@126.com+86 592 213 9573

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026